Baird Maintains an 'Outperform' on Optimer Pharmaceuticals (OPTR); Staying Put Despite Q2 Disappointment
Tweet Send to a Friend
Baird maintains an 'Outperform' on Optimer Pharmaceuticals (NASDAQ: OPTR) price target of $18.00 (from $19.00).
Aanlyst, Thomas Russo, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Aanlyst, Thomas Russo, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
